Primary sclerosing cholangitis - a comprehensive review

J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10.

Abstract

Primary sclerosing cholangitis (PSC) is a rare disorder characterised by multi-focal bile duct strictures and progressive liver disease. Inflammatory bowel disease is usually present and there is a high risk of cholangiocarcinoma and colorectal cancer. Most patients ultimately require liver transplantation, after which disease recurrence may occur. With limited therapeutic options and a lack of proven surveillance strategies, patients currently have significant unmet needs. In the present seminar, we provide a comprehensive review of the status of the field. We emphasise developments related to patient stratification and disease behaviour, and provide an overview of management options from a practical, patient-centered perspective. We survey advances made in the understanding of PSC pathogenesis and summarise the ongoing efforts to develop an effective therapy based on these insights.

Keywords: Cholangiocarcinoma; IgG4-associated cholangitis; Primary sclerosing cholangitis.

Publication types

  • Review

MeSH terms

  • Biopsy
  • Cholangitis, Sclerosing / diagnosis
  • Cholangitis, Sclerosing / etiology
  • Cholangitis, Sclerosing / genetics
  • Cholangitis, Sclerosing / therapy*
  • Genetic Predisposition to Disease
  • Humans
  • Liver / pathology
  • Liver Transplantation
  • Quality of Life